Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00767702 · ClinicalTrials.gov registry record

Use of Population Descriptors in Human Genetic Research

A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).

Completed
Registry status
18
Enrollment target

NCT00767702: Completed study, sponsored by National Human Genome Research Institute (NHGRI).

NCT00767702 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00767702 has completed, sponsored by National Human Genome Research Institute (NHGRI).

COMPLETED
Registry status
18 participants
Enrollment target

Study Summary

This study will explore scientists opinions and practices regarding the use of population descriptors (e.g., race, ethnicity, ancestry, geography and nationality) to describe a research study population. It will collect genetic researchers opinions, understandings and experiences studying human genetics and genetic variation. Scientists who are a principal investigator or co-principal investigator n a human genetic or genomic study of a common disease with at least preliminary data that uses population descriptors may be eligible for the study. Participants are asked to think about their study populations and how they are described in their research. They participate in two audio-taped semi-structured interviews that last from about 90 to 120 minutes. They may also participate in one or both of the following optional study components: * A third semi-structured interview that explores implementing a new method of describing study populations in data analysis. * 2 to 3 days of lab observation, in which a member of the study research team meets the lab members, observes daily activities and attends lab meetings.

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2008-09-18
Est. Completion 2012-08-08

What the finished NCT00767702 record still lists

NCT00767702 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00767702 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00767702 about?

NCT00767702 is a clinical study titled "Use of Population Descriptors in Human Genetic Research". This study will explore scientists opinions and practices regarding the use of population descriptors (e.g., race, ethnicity, ancestry, geography and nationality) to describe a research study population. It will collect genetic researchers opinions, understandings and experiences studying human gene...

What is the current status of trial NCT00767702?

This trial is currently completed. The enrollment target is 18 participants. The study started on 2008-09-18. Estimated completion is 2012-08-08.

Who is sponsoring clinical trial NCT00767702?

This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00767702, the US trial registry maintained by the National Library of Medicine. NCT00767702 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.